ARTICLE | Company News
Dendreon licenses Bayer antigens
September 26, 2001 7:00 AM UTC
Bayer (FSE:BAYG) granted DNDN licenses to two of its cancer antigens: carcinoembryonic antigen (CEA) and MN antigen, for use in DNDN's cancer vaccine research. CEA is expressed in multiple cancers, in...